“Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience

I. Vaxman, J. Abeykoon, A. Dispenzieri, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, Y. Hwa, A. Fonder, M. Hobbs, C. Reeder, T. Sher, S. Hayman, T. Kourelis, R. Warsame, E. Muchtar, N. Leung, R. Go, W. Gonsalves, M. SiddiquiR. A. Kyle, S. V. Rajkumar, McCullough C. Kristen, P. Kapoor, M. A. Gertz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of '“Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience'. Together they form a unique fingerprint.

Medicine & Life Sciences